Download
00408_2024_Article_679.pdf 1,27MB
WeightNameValue
1000 Titel
  • Human Bronchial Epithelial Cell Transcriptome Changes in Response to Serum from Patients with Different Status of Inflammation
1000 Autor/in
  1. Sivaraman, Kokilavani |
  2. Liu, Bin |
  3. Martinez-Delgado, Beatriz |
  4. Held, Julia |
  5. Büttner, Manuela |
  6. Illig, Thomas |
  7. Volland, Sonja |
  8. Gomez-Mariano, Gema |
  9. Jedicke, Nils |
  10. Yevsa, Tetyana |
  11. Welte, Tobias |
  12. DeLuca, David S. |
  13. Wrenger, Sabine |
  14. Olejnicka, Beata |
  15. Janciauskiene, Sabina |
1000 Verlag
  • Springer US
1000 Erscheinungsjahr 2024
1000 Publikationstyp
  1. Artikel |
1000 Online veröffentlicht
  • 2024-03-17
1000 Erschienen in
1000 Quellenangabe
  • 202(2):157-170
1000 Copyrightjahr
  • 2024
1000 Lizenz
1000 Verlagsversion
  • https://doi.org/10.1007/s00408-024-00679-1 |
  • https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11009779/ |
1000 Publikationsstatus
1000 Begutachtungsstatus
1000 Sprache der Publikation
1000 Abstract/Summary
  • <jats:title>Abstract</jats:title><jats:sec> <jats:title>Purpose</jats:title> <jats:p>To investigate the transcriptome of human bronchial epithelial cells (HBEC) in response to serum from patients with different degrees of inflammation.</jats:p> </jats:sec><jats:sec> <jats:title>Methods</jats:title> <jats:p>Serum from 19 COVID-19 patients obtained from the Hannover Unified Biobank was used. At the time of sampling, 5 patients had a WHO Clinical Progression Scale (WHO-CPS) score of 9 (severe illness). The remaining 14 patients had a WHO-CPS of below 9 (range 1–7), and lower illness. Multiplex immunoassay was used to assess serum inflammatory markers. The culture medium of HBEC was supplemented with 2% of the patient’s serum, and the cells were cultured at 37 °C, 5% CO<jats:sub>2</jats:sub> for 18 h. Subsequently, cellular RNA was used for RNA-Seq.</jats:p> </jats:sec><jats:sec> <jats:title>Results</jats:title> <jats:p>Patients with scores below 9 had significantly lower albumin and serum levels of E-selectin, IL-8, and MCP-1 than patients with scores of 9. Principal component analysis based on 500 “core genes” of RNA-seq segregated cells into two subsets: exposed to serum from 4 (I) and 15 (II) patients. Cells from a subset (I) treated with serum from 4 patients with a score of 9 showed 5566 differentially expressed genes of which 2793 were up- and 2773 downregulated in comparison with cells of subset II treated with serum from 14 patients with scores between 1 and 7 and one with score = 9. In subset I cells, a higher expression of <jats:italic>TLR4</jats:italic> and <jats:italic>CXCL8</jats:italic> but a lower <jats:italic>CDH1</jats:italic>, <jats:italic>ACE2</jats:italic>, and <jats:italic>HMOX1</jats:italic>, and greater effects on genes involved in metabolic regulation, cytoskeletal organization, and kinase activity pathways were observed.</jats:p> </jats:sec><jats:sec> <jats:title>Conclusion</jats:title> <jats:p>This simple model could be useful to characterize patient serum and epithelial cell properties.</jats:p> </jats:sec>
1000 Sacherschließung
lokal RNA-seq
lokal Chemokine/cytokine profile
lokal Acute lung inflammation
lokal Gene expression
lokal Immune hyper-activation
lokal Lung Inflammation
1000 Fächerklassifikation (DDC)
1000 Liste der Beteiligten
  1. https://frl.publisso.de/adhoc/uri/U2l2YXJhbWFuLCBLb2tpbGF2YW5p|https://frl.publisso.de/adhoc/uri/TGl1LCBCaW4=|https://frl.publisso.de/adhoc/uri/TWFydGluZXotRGVsZ2FkbywgQmVhdHJpeg==|https://frl.publisso.de/adhoc/uri/SGVsZCwgSnVsaWE=|https://frl.publisso.de/adhoc/uri/QsO8dHRuZXIsIE1hbnVlbGE=|https://frl.publisso.de/adhoc/uri/SWxsaWcsIFRob21hcw==|https://frl.publisso.de/adhoc/uri/Vm9sbGFuZCwgU29uamE=|https://frl.publisso.de/adhoc/uri/R29tZXotTWFyaWFubywgR2VtYQ==|https://frl.publisso.de/adhoc/uri/SmVkaWNrZSwgTmlscw==|https://frl.publisso.de/adhoc/uri/WWV2c2EsIFRldHlhbmE=|https://frl.publisso.de/adhoc/uri/V2VsdGUsIFRvYmlhcw==|https://frl.publisso.de/adhoc/uri/RGVMdWNhLCBEYXZpZCBTLg==|https://orcid.org/0000-0002-9733-6162|https://frl.publisso.de/adhoc/uri/T2xlam5pY2thLCBCZWF0YQ==|https://orcid.org/0000-0003-3228-8021
1000 Hinweis
  • DeepGreen-ID: 8e0ad6d4d7ba4a1d880dd3416811fb92 ; metadata provieded by: DeepGreen (https://www.oa-deepgreen.de/api/v1/), LIVIVO search scope life sciences (http://z3950.zbmed.de:6210/livivo), Crossref Unified Resource API (https://api.crossref.org/swagger-ui/index.html), to.science.api (https://frl.publisso.de/), ZDB JSON-API (beta) (https://zeitschriftendatenbank.de/api/), lobid - Dateninfrastruktur für Bibliotheken (https://lobid.org/resources/search)
1000 Label
1000 Förderer
  1. Deutsches Zentrum für Lungenforschung |
  2. Enterprise Europe Network Niedersachsen |
  3. Narodowe Centrum Nauki |
  4. ExcellGene SA |
  5. Medizinische Hochschule Hannover (MHH) |
1000 Fördernummer
  1. -
  2. -
  3. -
  4. -
  5. -
1000 Förderprogramm
  1. -
  2. -
  3. -
  4. -
  5. -
1000 Dateien
1000 Förderung
  1. 1000 joinedFunding-child
    1000 Förderer Deutsches Zentrum für Lungenforschung |
    1000 Förderprogramm -
    1000 Fördernummer -
  2. 1000 joinedFunding-child
    1000 Förderer Enterprise Europe Network Niedersachsen |
    1000 Förderprogramm -
    1000 Fördernummer -
  3. 1000 joinedFunding-child
    1000 Förderer Narodowe Centrum Nauki |
    1000 Förderprogramm -
    1000 Fördernummer -
  4. 1000 joinedFunding-child
    1000 Förderer ExcellGene SA |
    1000 Förderprogramm -
    1000 Fördernummer -
  5. 1000 joinedFunding-child
    1000 Förderer Medizinische Hochschule Hannover (MHH) |
    1000 Förderprogramm -
    1000 Fördernummer -
1000 Objektart article
1000 Beschrieben durch
1000 @id frl:6523746.rdf
1000 Erstellt am 2025-07-06T23:44:55.448+0200
1000 Erstellt von 322
1000 beschreibt frl:6523746
1000 Zuletzt bearbeitet 2025-07-16T13:45:36.153+0200
1000 Objekt bearb. Wed Jul 16 13:45:36 CEST 2025
1000 Vgl. frl:6523746
1000 Oai Id
  1. oai:frl.publisso.de:frl:6523746 |
1000 Sichtbarkeit Metadaten public
1000 Sichtbarkeit Daten public
1000 Gegenstand von

View source